Ching Yau Yi
Comptroller/Controller/Auditor bei CHEMOCENTRYX, INC.
Profil
Ching Yau Yi is currently the Chief Accounting Officer & Senior VP-Finance at ChemoCentryx, Inc. Prior to this, she was the Chief Accounting Officer at BridgeBio Pharma, Inc. from 2019 to 2022.
She also worked as the Vice President-Finance at Nektar Therapeutics from 2018 to 2019 and as a Controller at Theravance Biopharma, Inc. from 2013 to 2018.
Ms. Yi's former experience also includes working as a Senior Manager at Ernst & Young LLP from 2003 to 2013.
She received her undergraduate degree from Nanyang Technological University in 1999.
Aktive Positionen von Ching Yau Yi
| Unternehmen | Position | Beginn |
|---|---|---|
| CHEMOCENTRYX, INC. | Comptroller/Controller/Auditor | 06.06.2022 |
Ehemalige bekannte Positionen von Ching Yau Yi
| Unternehmen | Position | Ende |
|---|---|---|
| BRIDGEBIO PHARMA, INC. | Comptroller/Controller/Auditor | 01.03.2022 |
| NEKTAR THERAPEUTICS | Director of Finance/CFO | 01.10.2019 |
| THERAVANCE BIOPHARMA, INC. | Comptroller/Controller/Auditor | 01.05.2018 |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Corporate Officer/Principal | 01.11.2013 |
Ausbildung von Ching Yau Yi
| Nanyang Technological University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| NEKTAR THERAPEUTICS | Health Technology |
| BRIDGEBIO PHARMA, INC. | Health Technology |
| THERAVANCE BIOPHARMA, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
ChemoCentryx, Inc.
 ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology ChemoCentryx, Inc. is a biopharmaceutical company, which engages in the development and commercialization of medicines. It focuses on inflammatory disorders, autoimmune diseases, and cancer. Its drug candidates such as Avacopan and CCX140, selectively blocks a specific chemoattractant receptor, leaving the rest of the immune system intact. The company was founded by Thomas J. Schall in 1997 and is headquartered in San Carlos, CA. | Health Technology |
